MolecuLight All-in-One Oxygenation Clinical Utility

Part of paid clinical trials in Monroeville, Pennsylvania.

Sponsor
MolecuLight Inc.
Study ID
NCT07646938
Status
Completed

Conditions

  • Wounds

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • MolecuLightDX+ with OxySight Module — DEVICE
    MolecuLightDX+ with OxySight Module is an imaging device intended to acquire fluorescence, oxygenation, thermal, and measurement images of wounds.

Study Details

This is a prospective, clinical evaluation of the MolecuLightDX+ with OxySight Module in wound care.

Key Dates

Start date
Mar 25, 2026
Status verified
Jun 2026
Primary completion
Mar 27, 2026
Completion
Mar 27, 2026

Study Design

Enrollment
18 participants (actual)

Primary Outcome Measure

Tissue oxygenation informing fluorescence-guided debridement [ Time Frame: up to 1 month ]

Locations (1)

FacilityCityStateZIPSite coordinators
SerenaGroup MonroevilleMonroevillePennsylvania15146-

Find similar trials in Monroeville, PA

Related Studies